NCT01407887View on ClinicalTrials.gov

Efficacy and Safety of Artesunate-amodiaquine-methylene for Malaria Treatment in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

December 31, 2011

Conditions
Uncomplicated Falciparum Malaria
Interventions
DRUG

artesunate (AS) - amodiaquine (AQ) - methylene blue (MB)

The group AS-AQ-MB will receive once daily a fixed dose AS-AQ formulation combined with once daily MB over a three days period.

Trial Locations (1)

P.O. Box 34

Nouna Health District, Nouna

All Listed Sponsors
lead

Heidelberg University

OTHER

NCT01407887 - Efficacy and Safety of Artesunate-amodiaquine-methylene for Malaria Treatment in Children | Biotech Hunter | Biotech Hunter